bpc-157 intramuscular bioavailability rats dogs Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review Frontiers | Pharmacokinetics, distribution, metabolism,

A review of animal models of intervertebral disc degeneration: pathophysiology, regeneration, and translation to the clinic

Product Specifications Test Results Sample: AOD-9604 5mg Certificate of Analysis Certificates of Analysis Third-party tested for ~99% purity AOD-9604 Properties Source: PubChem Form: Lyophilized powder Unit size: 5mg/vial Unit quantity: 1 vial Molecular formula: C 78 H 123 N 23 O 23 S 2 Molecular weight: 1815.1 g/mol Synonym: AOD-9604, AOD 9604 Sequence: H-Tyr-Leu-Arg-Ile-Val-Gln-Cys(1)-Arg-Ser-Val-Glu-Gly-Ser-Cys(1)-Gly-Phe-OH CAS number: 221231-10-3 Frequently Asked Questions Related Products 3 of 45 products KPV (10mg) PNC-27 (10mg) How It Works Precision Synthesis Synthesized in dedicated, state of-the-art facilities

Cold vial + warm air = condensation of moisture inside

Property Detail Full Name Thymosin Beta-4 active fragment (TB-500) Amino Acids 43 (full T4 sequence) Active Region LKKTETQ (residues 17-23) Molecular Weight ~4,963 Da (full T4) Origin Thymus gland protein, ubiquitous in nucleated cells CAS Number 77591-33-4 (Thymosin Beta-4) FDA Status Not approved WADA Status Prohibited (S2 category) Is TB-500 FDA Approved

Apply short-term strategies (ice therapy, compression, elevation) during the first 3 to 7 days after injury